Abstract

Transforming growth factor-β1 (TGF-β1) is a pleiotropic factor sensed by most cells. It regulates a broad spectrum of cellular responses including hematopoiesis. In order to process TGF-β1-responses in time and space in an appropriate manner, there is a tight regulation of its signaling at diverse steps. The downstream signaling is mediated by type I and type II receptors and modulated by the ‘accessory’ receptor Endoglin also termed cluster of differentiation 105 (CD105). Endoglin was initially identified on pre-B leukemia cells but has received most attention due to its high expression on activated endothelial cells. In turn, Endoglin has been figured out as the causative factor for diseases associated with vascular dysfunction like hereditary hemorrhagic telangiectasia-1 (HHT-1), pre-eclampsia, and intrauterine growth restriction (IUPR). Because HHT patients often show signs of inflammation at vascular lesions, and loss of Endoglin in the myeloid lineage leads to spontaneous inflammation, it is speculated that Endoglin impacts inflammatory processes. In line, Endoglin is expressed on progenitor/precursor cells during hematopoiesis as well as on mature, differentiated cells of the innate and adaptive immune system. However, so far only pro-monocytes and macrophages have been in the focus of research, although Endoglin has been identified in many other immune system cell subsets. These findings imply a functional role of Endoglin in the maturation and function of immune cells. Aside the functional relevance of Endoglin in endothelial cells, CD105 is differentially expressed during hematopoiesis, arguing for a role of this receptor in the development of individual cell lineages. In addition, Endoglin expression is present on mature immune cells of the innate (i.e., macrophages and mast cells) and the adaptive (i.e., T-cells) immune system, further suggesting Endoglin as a factor that shapes immune responses. In this review, we summarize current knowledge on Endoglin expression and function in hematopoietic precursors and mature hematopoietic cells of different lineages.

Highlights

  • Transforming growth factor-β1 (TGF-β1) is a pleiotropic factor sensed by most cells

  • The function of Endoglin is not limited to Endoglin expressing cells, since this receptor itself can directly be a part of the paracrine communication by the proteolytical release of the extracellular domain as soluble Endoglin from the cell surface [45]. sEng is increased in pre-eclamptic woman and has been functionally linked

  • It has been anticipated that Endoglin expression/function is not restricted to endothelial cells (EC)

Read more

Summary

Structural and Functional Aspects of Endoglin

Endoglin is a class I, single-membrane spanning receptor with an apparent molecular weight of 95 kDa containing a short cytoplasmic and a modular extracellular domain. In contrast to the signaling receptors, Endoglin possesses only a short intracellular domain with no intrinsic kinase activity This domain represents a hub for interaction with TGF-β/bone morphogenetic protein (BMP)-receptors, integrins and proteins regulating migration and trafficking such as zyxin, zyxin-related protein (ZRP)-1, β-arrestin, and the GAIP C-terminus-interacting protein (GIPC) [9,10,11,12,13,14]. SEng and the membrane bound full-length Endoglin can be released by cells as a cargo of exosomes [4] These studies demonstrate that under physiological conditions (i) Endoglin is functionally expressed outside ECs, (ii) Endoglin is a co-receptor primarily (but not exclusively) for ligands of the TGF-β-superfamily, and (iii) Endoglin impacts the function of cells expressing the receptor, and acts in a paracrine manner

The Female Reproductive System
Vascular Homeostasis
Endoglin in the Hematopoietic System
Fetal Hematopoiesis
Adult Hematopoiesis
Expression of Endoglin in Individual Hematopoietic Lineages
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call